Table 2.
Clear Cell | Papillary | Chromophobe | Other | P | Clear Cell RCCa | P | Papillary RCCb | P | |
---|---|---|---|---|---|---|---|---|---|
OR (95% CI) | OR (95% CI) | ||||||||
Racial/ethnic minority groups compared to NHWs | <.001 | <.001 | <.001 | ||||||
NHW | 147 523 (72.5) | 30 608 (15.0) | 13 850 (6.8) | 11 408 (5.6) | Reference | Reference | |||
AI/AN | 1077 (86.3) | 68 (5.4) | 41 (3.3) | 62 (5.0) | 2.18 (1.85‐2.58) | 0.37 (0.29‐0.48) | |||
NHB | 12 876 (43.9) | 11 749 (40.0) | 2317 (7.9) | 2418 (8.2) | 0.29 (0.28‐0.29) | 4.01 (3.90‐4.13) | |||
AA | 3585 (77.4) | 481 (10.4) | 312 (6.7) | 253 (5.5) | 1.39 (1.30‐1.50) | 0.62 (0.56‐0.69) | |||
HA | 23 570 (74.4) | 3924 (12.4) | 2369 (7.5) | 1817 (5.7) | 1.08 (1.05‐1.11) | 0.85 (0.81‐0.88) | |||
HA groups compared to NHWs | <.001 | <.001 | <.001 | ||||||
NHW | Reference | Reference | |||||||
Mexican/Chicano | 2126 (83.5) | 153 (6.0) | 145 (5.7) | 122 (4.8) | 2.00 (1.78‐2.23) | 0.38 (0.32‐0.45) | |||
Puerto Rican | 423 (70.4) | 85 (14.1) | 60 (10.0) | 33 (5.5) | 0.89 (0.74‐1.07) | 1.01 (0.80‐1.29) | |||
Cuban | 345 (66.7) | 79 (15.3) | 46 (8.9) | 47 (9.1) | 0.78 (0.65‐0.94) | 1.01 (0.79‐1.29) | |||
South or Central American | 807 (77.7) | 87 (8.4) | 91 (8.8) | 54 (5.2) | 1.37 (1.17‐1.60) | 0.50 (0.40‐0.64) | |||
Dominican | 92 (52.0) | 43 (24.3) | 26 (14.7) | 16 (9.0) | 0.39 (0.29‐0.53) | 1.98 (1.38‐2.84) |
Abbreviations: AA, Asian American; AI/AN, American Indian and Alaska Native; HA, Hispanic American; NHB, Non‐Hispanic Black; NHW, Non‐Hispanic White; RCC, renal cell carcinoma.
Clear cell RCC compared to other subtypes adjusting for age, gender, Charlson/Deyo Score, and facility type.
Papillary RCC compared to other subtypes adjusting for age, gender, Charlson/Deyo Score, and facility type.